A groundbreaking shift in Canadian drug policy has happened, as the authorities announce the availability of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were heavily restricted, but a growing body of studies suggests they may offer aid for psychological conditions like PTSD. The new policy represents a key step